| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052616640 |
| P356 | DOI | 10.1038/SJ.NPP.1300661 |
| P698 | PubMed publication ID | 15668723 |
| P5875 | ResearchGate publication ID | 8062464 |
| P2093 | author name string | Roberto W Invernizzi | |
| Angelo Battaglia | |||
| Giuliano Renoldi | |||
| Stefania Parini | |||
| P2860 | cites work | Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus | Q48831382 |
| 3H-noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment | Q49013171 | ||
| Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients | Q49073509 | ||
| Combined Treatment with Imipramine and Mianserin | Q60445521 | ||
| Cell-type-specific expression of catecholamine transporters in the rat brain | Q72096428 | ||
| Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors | Q72877132 | ||
| Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study | Q28345792 | ||
| Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex | Q28345858 | ||
| Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs | Q31962157 | ||
| Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors | Q31976190 | ||
| Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder | Q34158981 | ||
| Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices | Q34307273 | ||
| Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors. | Q35041626 | ||
| Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain | Q35041707 | ||
| Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies | Q35885410 | ||
| Local regulation of adrenergic neurotransmission | Q37625932 | ||
| Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents | Q39100289 | ||
| Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane | Q39107047 | ||
| Feedback Inhibition of Brain Noradrenaline Neurons by Tricyclic Antidepressants: α-Receptor Mediation | Q40186365 | ||
| Current advances and trends in the treatment of depression | Q41028584 | ||
| Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. | Q41169050 | ||
| Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action | Q41368491 | ||
| Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats | Q41389778 | ||
| Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor | Q41486722 | ||
| Central alpha 2-autoreceptors: agonist dissociation constants and recovery after irreversible inactivation | Q42064436 | ||
| Clorgyline and desipramine alter the sensitivity of [3H]noradrenaline release to calcium but not to clonidine | Q42508476 | ||
| Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex | Q42523098 | ||
| Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor | Q43503047 | ||
| Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons | Q43650960 | ||
| Central catecholamine neuron systems: anatomy and physiology of the dopamine systems | Q44795666 | ||
| Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine | Q47777731 | ||
| Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS. | Q48278545 | ||
| Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission | Q48341314 | ||
| Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors | Q48433394 | ||
| Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine | Q48450328 | ||
| Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex | Q48456581 | ||
| Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study | Q48788302 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | norepinephrine | Q186242 |
| P304 | page(s) | 1048-1055 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus | |
| P478 | volume | 30 |
| Q37887038 | Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively? |
| Q46033276 | Early induction of CREB activation and CREB-regulating signalling by antidepressants. |
| Q47946543 | Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study. |
| Q36067334 | Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance |
| Q55421497 | Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs). |
| Q42446087 | Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior |
| Q34517414 | Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. |
| Q41665042 | Reduced signal transduction by 5‐HT4 receptors after long‐term venlafaxine treatment in rats |
| Q46439905 | Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain |
| Q35371943 | The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo. |
| Q30474844 | The noradrenergic symptom cluster: clinical expression and neuropharmacology |
| Q48228347 | The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression |
| Q34295208 | α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy |
Search more.